These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26422864)

  • 1. Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey.
    Pekel Ö; Ergör G; Günay T; Baydur H; Choussein B; Budak R; Doğanay S
    Turk J Med Sci; 2015; 45(4):895-901. PubMed ID: 26422864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatments for smoking cessation.
    Cahill K; Stevens S; Lancaster T
    JAMA; 2014 Jan; 311(2):193-4. PubMed ID: 24399558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco smoking cessation management: integrating varenicline in current practice.
    Galanti LM
    Vasc Health Risk Manag; 2008; 4(4):837-45. PubMed ID: 19066000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methods and results of smoking cessation in cancer smoker's].
    Dautzenberg B
    Bull Cancer; 2012 Nov; 99(11):1007-15. PubMed ID: 23131278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
    Kasza KA; Hyland AJ; Borland R; McNeill AD; Bansal-Travers M; Fix BV; Hammond D; Fong GT; Cummings KM
    Addiction; 2013 Jan; 108(1):193-202. PubMed ID: 22891869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline: for smoking cessation.
    Rao J; Shankar PK
    Kathmandu Univ Med J (KUMJ); 2009; 7(26):162-4. PubMed ID: 20071853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation and COPD.
    Tønnesen P
    Eur Respir Rev; 2013 Mar; 22(127):37-43. PubMed ID: 23457163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
    Johnson TS
    J Am Acad Nurse Pract; 2010 Oct; 22(10):557-63. PubMed ID: 21040090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment options in smoking cessation.
    Crain D; Bhat A
    Hosp Pract (1995); 2010 Feb; 38(1):53-61. PubMed ID: 20469625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine dependence and smoking cessation.
    Tan L; Tang Q; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1049-57. PubMed ID: 19952392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
    Getsios D; Marton JP; Revankar N; Ward AJ; Willke RJ; Rublee D; Ishak KJ; Xenakis JG
    Pharmacoeconomics; 2013 Sep; 31(9):767-80. PubMed ID: 23821436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex difference in response to varenicline for smoking cessation.
    Gorelick DA
    Am J Psychiatry; 2015 Apr; 172(4):394-5. PubMed ID: 25827037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.